Tempest Therapeutics, Inc. Share Price
TPSTTempest Therapeutics, Inc. Stock Performance
Open $2.48 | Prev. Close $2.44 | Circuit Range N/A |
Day Range $2.44 - $2.48 | Year Range $2.31 - $12.48 | Volume 413 |
Average Traded $2.45 |
Tempest Therapeutics, Inc. Share Price Chart
About Tempest Therapeutics, Inc.
Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its clinical-stage lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study. Tempest Therapeutics, Inc. is headquartered in Brisbane, California. Tempest Therapeutics, Inc. operates as a subsidiary of Inception Sciences, Inc.
Tempest Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Feb-26 | $2.48 | $2.42 | +8.74% |
05-Feb-26 | $2.17 | $2.23 | -3.67% |
04-Feb-26 | $2.31 | $2.31 | -7.03% |
03-Feb-26 | $2.49 | $2.49 | +0.81% |
02-Feb-26 | $2.47 | $2.47 | -9.69% |
30-Jan-26 | $2.73 | $2.73 | -3.70% |
29-Jan-26 | $2.75 | $2.84 | +1.97% |
FAQs on Tempest Therapeutics, Inc. Share Price
Can I buy Tempest Therapeutics, Inc. shares in India?
What is the share price of Tempest Therapeutics, Inc.?
What is the 5 year returns of Tempest Therapeutics, Inc.?
What are the high & low stock price of Tempest Therapeutics, Inc. today?
What is the 52-week high and low of Tempest Therapeutics, Inc. stock?